Evidence map›Paper›PMID 27630217›Full record

ArticleJournal of leukocyte biology2017

Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.

Anju Singh, Tabassum Rahman, Rose Bartiss, Alireza Arabshahi, Jeevan Prasain, Stephen Barnes, Florin Marcel Musteata, Timothy J Sellati

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Host-based lipid inflammation drives pathogenesis inProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Anju SinghTrudeau Institute, Saranac Lake, New York, USA.
Tabassum RahmanCenter for Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.
Rose BartissTrudeau Institute, Saranac Lake, New York, USA.
Alireza ArabshahiTargeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA; and.
Jeevan PrasainTargeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA; and.
Stephen BarnesTargeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA; and.
Florin Marcel MusteataDepartment of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
Timothy J SellatiTrudeau Institute, Saranac Lake, New York, USA; tsellati@southernresearch.org.
Trudeau Institute · USUniversity of Alabama at Birmingham · USAlbany College of Pharmacy and Health Sciences · USAlbany Medical Center Hospital · USTarget (United States) · US

Funding

Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-TargetingR01AI100138 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J, HAZLETT, KARSTEN R.O. · 2013 to 2017
$2.9M
NIAID NIH HHS R01 AI100138
6 · The paper itself

Abstract

Respiratory infection with Francisella tularensis (Ft) is characterized by a muted, acute host response, followed by sepsis-like syndrome that results in death. Infection with Ft establishes a principally anti-inflammatory environment that subverts host-cell death programs to facilitate pathogen replication. Although the role of cytokines has been explored extensively, the role of eicosanoids in tularemia pathogenesis is not fully understood. Given that lipoxin A

Indexed as

MetabolomeAcute DiseaseAnimalsApoptosisArachidonate 5-LipoxygenaseBone Marrow CellsCell DeathChemokinesChlorobenzenesChronic DiseaseDinoprostoneDisease SusceptibilityDown-RegulationFrancisella tularensisImmunityIndolesArachidonate 5-LipoxygenaseChemokinesChlorobenzenesDinoprostoneIndolesInflammation MediatorsLeukotriene B4lipoxin A4LipoxinsMK-886anti-inflammatorycytokinesinflammationlipid mediators

Identifiers

PMID27630217
PMCPMC5235906
OpenAlexW2518921575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.